Katelyn Baker
Well-Known Member
A group of local doctors is planning to open Maryland's first testing lab for medical marijuana.
The state legislature approved medical marijuana back in 2013, but officials have not yet awarded the 15 licenses to growers.
Dr. Andrew Rosenstein, a gastroenterologist at St. Joseph's Medical Center, is CEO of Steep Hill Maryland.
He says they will work to make sure patients who are using medical marijuana are getting the best product they can.
"Clearly when you look around the country, there have been some issues with standardization in labs and some quality issues. Our job as physicians in Maryland, is to raise the bar and create an FDA like standard for the patients of Maryland so they get a safe cannabis medicine," Rosenstein says.
Dr. Rosenstein says they are just handling compliance and testing of medical cannabis. The growers will have to have their products tested by labs like his before it goes to the market. Rosenstein expects it will take them six months to a year to get their first products to market once the licenses are awarded to the growers.
You can read more about the first planned medical marijuana testing lab below.
June 29, 2016 Columbia, MD - Steep Hill Maryland announces its plans to open the state's first full-service, physician-led medical cannabis testing laboratory in Columbia, Maryland, bringing advanced scientific tools and methodology to the state through a model leveraging cannabis expertise, deep medical and scientific knowledge,and the highest standards of oversight. Steep Hill Maryland is operated as a licensee of Steep Hill, which is headquartered in Berkeley, CA and recognized as the global leader in cannabis testing and analytics.
Steep Hill Maryland's CEO, Andrew Rosenstein,MD, a board-certified gastroenterologist who has been practicing for two decades in the Baltimore area, said, "Our priority is to make sure that medical cannabis is a safe product for the community. As a physician who treats many patients with cancer and other debilitating conditions, I am aware that there are patients who can benefit from medical cannabis to treat pain and suffering, for which they have found no other relief. By establishing Steep Hill Maryland, my colleagues and I are bringing the latest technology and state-of-the-art laboratory testing to Maryland so that patients can trust they are receiving a safe product once Maryland's program is operational. We see it as our responsibility and our mission to help ensure safety for this new therapeutic industry. To our knowledge, this is the first physician-led medical cannabis testing facility in the U.S."
Steep Hill President and CEO Jmichaele Keller said, "We are especially proud that this highly qualified team of medical professionals chose to partner with us and ulitize our testing technology. With cannabis becoming accepted as medicine and therapy in cancer treatment, epilepsy and for other known medical conditions in over 30 states, bringing the highest medical standards to all aspects of the industry is critical. We believe Steep Hill Maryland will set the healthcare standard for the industry. They will benefit immediately from our extensive knowledge of the cannabis plant and our proprietary testing technology and, as we work together,we will all benefit from the Steep Hill Maryland team's extensive medical knowledge. This marks the beginning of anew era in cannabis patient safety."
Testing medical cannabis involves many types of safety screening and potency analysis. During safety screening, a battery of tests detects contamination such as heavy metals, molds, pesticides,and other impurities. Potency analysis quantifies the strength and the particular makeup of the medical cannabis, including the percentage of the major cannabinoids, which include THC, CBD, CBG, CBN and others. The Steep Hill Maryland team brings experience in anatomic pathology tests and molecular diagnostics to support rigorous quality control. According to Dr. Rosenstein, "We are well-versed in compliance, quality, and patient safety because our current laboratories and endoscopy centers are certified by The Joint Commission, CLIA(Clinical Laboratory Improvement Amendments), Medicare, and CAP (College of American Pathologists). As we do in all of our other physician-led endeavors, we will bring the highest level of scientific and medical standards to medical cannabis testing."
Steep Hill Maryland's leadership team also includes: Chief Scientific Officer, Charles J. Sailey, MD, MS, board-certified clinical and molecular genetics pathologist;Chief Operating Officer, Adnan Khan, MD, board-certified pathologist; Chief Financial Officer, Marc Rosenstein, CPA, MBA; Vice President, Amin Khan, MD,board-certified gastroenterologist/hepatologist; Director of Business Development, Phillip Stripling.
Steep Hill Maryland's laboratory is planning to locate in Columbia, Maryland to conveniently serve licensed Maryland growers and processors.
ABOUT STEEP HILL MARYLAND Green Analytics MD, LLC d/b/a Steep Hill Maryland is operated as a licensee of Steep Hill,which is headquartered in Berkeley, CA and recognized as the global leader incannabis testing and analytics. Launching operations in 2016, Steep Hill Maryland will be run by Dr. Andrew Rosenstein, a board-certified gastroenterologist who has been practicing for two decades in the Baltimore area, and a complimentary team of board-certified healthcare professionals. Steep Hill Maryland was founded with the goal of bringing world-class testing and safety standards to patients in the state of Maryland, and to help Maryland set the example for future states to come. More information about cannabis testing, please visit our website: Steep Hill Labs | Global Leader in Cannabis Testing and Analytics
ABOUT STEEP HILL Founded in California in 2008, Steep Hill Labs, Inc. is a science and technology firm that has become the industry leader in cannabis testing and analytics. With labs in five states - soon to be seven with Maryland and now Alaska launching in 2016 - along with a new facility in Jamaica, Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California - the first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann, QuantaCann2, GenKit and Steep Hill Express. Steep Hill provides expert consulting services to many states, countries and municipalities, and the company is developing proprietary genetic testing,mapping and trademark protection services for the industry as well.
News Moderator: Katelyn Baker 420 MAGAZINE ®
Full Article: Local Docs Set To Open First MD Medical Marijuana Testing Lab
Author: Anne Kramer
Contact: 410-467-3000
Photo Credit: Steep Hill Maryland
Website: WBAL Radio 1090 AM
The state legislature approved medical marijuana back in 2013, but officials have not yet awarded the 15 licenses to growers.
Dr. Andrew Rosenstein, a gastroenterologist at St. Joseph's Medical Center, is CEO of Steep Hill Maryland.
He says they will work to make sure patients who are using medical marijuana are getting the best product they can.
"Clearly when you look around the country, there have been some issues with standardization in labs and some quality issues. Our job as physicians in Maryland, is to raise the bar and create an FDA like standard for the patients of Maryland so they get a safe cannabis medicine," Rosenstein says.
Dr. Rosenstein says they are just handling compliance and testing of medical cannabis. The growers will have to have their products tested by labs like his before it goes to the market. Rosenstein expects it will take them six months to a year to get their first products to market once the licenses are awarded to the growers.
You can read more about the first planned medical marijuana testing lab below.
June 29, 2016 Columbia, MD - Steep Hill Maryland announces its plans to open the state's first full-service, physician-led medical cannabis testing laboratory in Columbia, Maryland, bringing advanced scientific tools and methodology to the state through a model leveraging cannabis expertise, deep medical and scientific knowledge,and the highest standards of oversight. Steep Hill Maryland is operated as a licensee of Steep Hill, which is headquartered in Berkeley, CA and recognized as the global leader in cannabis testing and analytics.
Steep Hill Maryland's CEO, Andrew Rosenstein,MD, a board-certified gastroenterologist who has been practicing for two decades in the Baltimore area, said, "Our priority is to make sure that medical cannabis is a safe product for the community. As a physician who treats many patients with cancer and other debilitating conditions, I am aware that there are patients who can benefit from medical cannabis to treat pain and suffering, for which they have found no other relief. By establishing Steep Hill Maryland, my colleagues and I are bringing the latest technology and state-of-the-art laboratory testing to Maryland so that patients can trust they are receiving a safe product once Maryland's program is operational. We see it as our responsibility and our mission to help ensure safety for this new therapeutic industry. To our knowledge, this is the first physician-led medical cannabis testing facility in the U.S."
Steep Hill President and CEO Jmichaele Keller said, "We are especially proud that this highly qualified team of medical professionals chose to partner with us and ulitize our testing technology. With cannabis becoming accepted as medicine and therapy in cancer treatment, epilepsy and for other known medical conditions in over 30 states, bringing the highest medical standards to all aspects of the industry is critical. We believe Steep Hill Maryland will set the healthcare standard for the industry. They will benefit immediately from our extensive knowledge of the cannabis plant and our proprietary testing technology and, as we work together,we will all benefit from the Steep Hill Maryland team's extensive medical knowledge. This marks the beginning of anew era in cannabis patient safety."
Testing medical cannabis involves many types of safety screening and potency analysis. During safety screening, a battery of tests detects contamination such as heavy metals, molds, pesticides,and other impurities. Potency analysis quantifies the strength and the particular makeup of the medical cannabis, including the percentage of the major cannabinoids, which include THC, CBD, CBG, CBN and others. The Steep Hill Maryland team brings experience in anatomic pathology tests and molecular diagnostics to support rigorous quality control. According to Dr. Rosenstein, "We are well-versed in compliance, quality, and patient safety because our current laboratories and endoscopy centers are certified by The Joint Commission, CLIA(Clinical Laboratory Improvement Amendments), Medicare, and CAP (College of American Pathologists). As we do in all of our other physician-led endeavors, we will bring the highest level of scientific and medical standards to medical cannabis testing."
Steep Hill Maryland's leadership team also includes: Chief Scientific Officer, Charles J. Sailey, MD, MS, board-certified clinical and molecular genetics pathologist;Chief Operating Officer, Adnan Khan, MD, board-certified pathologist; Chief Financial Officer, Marc Rosenstein, CPA, MBA; Vice President, Amin Khan, MD,board-certified gastroenterologist/hepatologist; Director of Business Development, Phillip Stripling.
Steep Hill Maryland's laboratory is planning to locate in Columbia, Maryland to conveniently serve licensed Maryland growers and processors.
ABOUT STEEP HILL MARYLAND Green Analytics MD, LLC d/b/a Steep Hill Maryland is operated as a licensee of Steep Hill,which is headquartered in Berkeley, CA and recognized as the global leader incannabis testing and analytics. Launching operations in 2016, Steep Hill Maryland will be run by Dr. Andrew Rosenstein, a board-certified gastroenterologist who has been practicing for two decades in the Baltimore area, and a complimentary team of board-certified healthcare professionals. Steep Hill Maryland was founded with the goal of bringing world-class testing and safety standards to patients in the state of Maryland, and to help Maryland set the example for future states to come. More information about cannabis testing, please visit our website: Steep Hill Labs | Global Leader in Cannabis Testing and Analytics
ABOUT STEEP HILL Founded in California in 2008, Steep Hill Labs, Inc. is a science and technology firm that has become the industry leader in cannabis testing and analytics. With labs in five states - soon to be seven with Maryland and now Alaska launching in 2016 - along with a new facility in Jamaica, Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California - the first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann, QuantaCann2, GenKit and Steep Hill Express. Steep Hill provides expert consulting services to many states, countries and municipalities, and the company is developing proprietary genetic testing,mapping and trademark protection services for the industry as well.
News Moderator: Katelyn Baker 420 MAGAZINE ®
Full Article: Local Docs Set To Open First MD Medical Marijuana Testing Lab
Author: Anne Kramer
Contact: 410-467-3000
Photo Credit: Steep Hill Maryland
Website: WBAL Radio 1090 AM
